SMi, the industry leaders in respiratory events, presents the 7th annual conference... COPD.19th & 20th Oct 2015 | Holiday Inn Regents Park Hotel, London UK
SMi's 4th annual Cancer Vaccines conference returns to London this autumn to strengthen knowledge of targeted immunotherapies taking the foreground in revolutionizing cancer vaccines.
4th International Conference and Exhibition on Cell & Gene Therapy
OMICS International welcomes you to attend the 4th International Conference and Exhibition on Cell & Gene Therapy during August 10-12, 2015 at London, United Kingdom
SMi's 14th Annual Drug Design Conference will present attendees with an in-depth view into the developments and challenges within the Drug Design field | 16-17 Feb 2015, London UK
The Healthcare IT provides a platform to benchmark with an exclusive group of senior peers & solution providers to discuss how public & private organisations can drive greater efficiencies & improve quality of care.
Latest on 112-based emergency call legislation and end to end security
Join SMi's Latest on 112-based emergency call legislation and end to end security for a digital society event on 21 Oct 14, to reflect on the status both of eCall and ERA GLONASS and end2end security
COPD 2014 will include topical and current sessions, such as Patient Care and The Future of COPD, as well as presenting attendees with in-depth information on exacerbation and comorbidities, clinical trial design, drug development and market access.
SLAS, the Society for Laboratory and Automation Screening, is delighted to announce 3 One-day Short Courses to be held alongside the ELRIG Drug Discovery event on Monday, 1 September 2014 at Manchester Central, UK.
SMi is launching its inaugural Immunogenicity Conference, taking place in London on the 14th and 15th July. This two day event is designed to enhance SMi
Simulating Clinical Trials Using The FACTS Software Package
Join SMi's Simulating Clinical Trials Using the FACTS Software Package event on the 9 July in London, to hear how simulation of clinical trials is used in the trial design process and how it benefits.
This half day masterclass under the expertise of Klaus Rose Consulting, will provide a focus on: paediatric clinical trials, legislation considerations, Paediatric Investigation Plan and the impact of paediatric legislations in both US and EU
Join our Lyophilisation forum and gain insight into current successes and challenges that leading pharma and biotech organisations are facing in the freeze-drying field
Manufacturing Operation Strategy Planning for the Pharma/Biotech Industry
Join SMi's Manufacturing Operation Strategy Planning for the Pharma/Biotech Industry in 2014 event on the 7 July in London, to ensure your manufacturing network and capabilities grow efficiently
As the global Peptide Therapeutics market is expected to reach over $25 billion by 2018, the market is strongly trying to develop new peptide therapeutics and better formulations to enhance drug delivery.
This event will bring together industry leaders from big pharma companies, biotech companies, regulatory agencies and academia to discuss the latest developments in biobanking.
ADC Summit 2014Making your smart bomb smarter - creating innovative antibody-drug conjugates19th & 20th May 2014Holiday Inn Regents Park Hotel, London UK
Pain Therapeutics, Assess Alternative Approaches to Animal Models to Minimise the Translational Gap and Accelerate Market Access19th & 20th May 2014Holiday Inn Regents Park Hotel, London, UK
SMi present the 13th annual event:Advances & Progress in Drug DesignDelivering practical solutions to drug delivery challenges17-18 FEBRUARY 2014 | Marriott Regents Park Hotel, London UK
Attitudes across the Atlantic are slowly changing, and with the introduction of new legislation to help simplify biosimilar registration we take a look at how this has affected companies involved.
For those involved in the analysis of safety data this will provide insight into both what the expectations of the new legislation are as well as practical approaches to performing such activities. Essential whether a generic or innovator Company.
Getting your ADCs to the clinic: Considerations for early stage development
The development of existing or novel monoclonal antibodies as drug-conjugates to increase the targeted clinical effect of these proteins has rapidly increased in recent years.
The highly anticipated and respected 12th annual Clinical Trials in CNS Conference returns to London with a two day content packed agenda featuring new approaches taken in this field towards a number of neurodegenerative disorders,
Following on from our hugely successful Cell-Based Assays conference in 2012, this year's agenda will provide a global forum for senior level decision makers and those working within Cell-Based Assays to meet.
We are delighted to announce SMi's European Pharmaceutical Pricing & Reimbursement, now in its 19th year, this event has been one of the oldest market leaders in the pharmaceutical industries calendar for some time.
The use of 'rapid testing' techniques is becoming more prevalent in microbiology laboratories, as they strive to produce faster and more accurate results to enhance product safety.
recent finding in areas such as: current targets for analgesic development, personalised medicine, the cannabinoid approach, imaging modalities, experimental models in early phase clinical development and improving clinical trial success rates
The only conference in Europe to focus specifically on adaptive designs. Learn how to implement an adaptive design CT for your drug development from initial processes in managing trials to choosing the right time to implement change.
Hear, from the global expert speaking faculty, how controlled release products and drugs have developed over the past 12 months. This is the only conference in Europe to focus specifically on controlled release.
This fast-paced field and bring together senior representatives from industry and academia to discuss Statistical Issues in CADD, Binding Site Solvent Analysis, Structure-Based Lead Discovery and G-protein-coupled receptors.
the latest developments and procedures used in the identification and prevention of contaminating agents, updates on new rules and regulations and the challenges facing the Pharmaceutical Microbiology industry.
From Obamacare to AMNOG, this event will provide a unique opportunity to understand HTA evolution from a payer perspective and learn how to plan and develop effective and appropriate pricing strategies.
...to speed your paediatric medicine to marketThe very different beasts of Intellectual Property, Ethics and Recruitment prowl the drug development process. All have one thing in common - hunger for deadlines.
This masterclass will focus on the importance of preparation of the product lifecycle, as well as case study led discussions on development plans to identify and develop relationships with opinion leaders and reap the benefits
Led by the expertise of the Oxon Epidemiology team, this unique masterclass will explore the purpose of the PSUR and th structure of benefit-risk analysis in this new paradigm.
With leading members of the industry gathering together to discuss, learn and explore the industry, the conference provides a fantastic forum for the most up to date look at cold chain management strategies and supply chain regulations.
Cell-Based Assays 2012 aims to show you the most recent developments to in assay technology to date. 3D cell culture is widely being touted as increasingly essential as this technique can with greater accuracy re-create in vivo behaviour...